v3.26.3
OTHER OPERATING (GAINS) EXPENSES, NET - Narrative (Details)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Jul. 31, 2025
employee
Jun. 30, 2025
USD ($)
Sep. 30, 2026
USD ($)
Sep. 30, 2025
USD ($)
Sep. 30, 2026
USD ($)
Sep. 30, 2025
USD ($)
Loss Contingencies [Line Items]            
Acquisition-related expenses     $ 7,384 $ 0 $ 7,384 $ 0
Divestiture-related expenses     705 0 6,636 0
Separation costs     611 0 611 0
Changes in contingent consideration     (14,430) 625 (15,044) (2,407)
Number of employees | employee 71          
Total workforce (in percent) 8.00%          
Employee termination benefit charges       3,700   3,700
Legal settlement     0 0 0 7,000
Impairment of acquired IPR&D     0 25,866 0 25,866
Acquisition-related expenses     $ 0 (280) $ 0 2,222
Acquired IPR&D            
Loss Contingencies [Line Items]            
Impairment of acquired IPR&D       25,900   25,900
Carrying value of impairment of intangible assets       33,900   33,900
Fair value of impairment of intangible assets       8,000   8,000
Research Development Foundation            
Loss Contingencies [Line Items]            
Repayments for royalties   $ (23,100)   $ (23,100)   $ (23,100)